Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Cash flows from operating activities:
Net income including noncontrolling interests	$ 73,526	$ 150,157
Adjustments to reconcile net income to net cash from operating activities:
Depreciation and amortization	26,730	24,056
Share-based compensation expense related to equity classified awards	15,512	19,899
Non-cash restructuring and other related charges	3,928	1,171
Amortization and write-off of program rights	223,982	205,275
Amortization of deferred carriage fees	6,783	2,710
Unrealized foreign currency transaction loss (gain)	7,848	(4,501)
Amortization of deferred financing costs and discounts on indebtedness	1,918	1,954
Loss on extinguishment of debt	2,908	0
Bad debt expense	1,211	2,353
Deferred income taxes	15,900	(8,858)
Write-down of non-marketable equity securities and note receivable	20,000	17,741
Other, net	1,044	1,142
Changes in assets and liabilities:
Accounts receivable, trade (including amounts due from related parties, net)	27,178	(1,429)
Prepaid expenses and other assets	17,532	(26,233)
Program rights and obligations, net	(221,627)	(190,651)
Income taxes payable	369	40,114
Deferred revenue	9,522	(4,200)
Deferred carriage fees, net	(15,484)	(422)
Accounts payable, accrued liabilities and other liabilities	(20,372)	(58,591)
Net cash provided by operating activities	198,408	171,687
Cash flows from investing activities:
Capital expenditures	(12,916)	(22,053)
Return of capital from investees	0	3,908
Principal payment received on loan to investee	1,250	0
Proceeds from sale of investments	10,000	0
Net cash used in investing activities	(1,666)	(18,145)
Cash flows from financing activities:
Proceeds from the issuance of long-term debt	5,000	2,521
Principal payments on long-term debt	(209,375)	(3,238)
Deemed repurchases of restricted stock units	(8,858)	(22,959)
Purchase of treasury stock	(85,957)	(991)
Proceeds from stock option exercises	0	4,630
Principal payments on finance lease obligations	(781)	(1,309)
Distributions to noncontrolling interests	(3,081)	(5,629)
Net cash used in financing activities	(303,052)	(26,975)
Net increase (decrease) in cash and cash equivalents from operations	(106,310)	126,567
Effect of exchange rate changes on cash and cash equivalents	(5,731)	2,229
Cash and cash equivalents at beginning of period	816,170	554,886
Cash and cash equivalents at end of period	$ 704,129	$ 683,682